APP and Alzheimer disease: While identified familial genetic mutations in amyloid precursor protein (APP) and presenilin [10–12], a component of gamma-secretase complex [13], are responsible for only about 1% of all AD cases, the sporadic form afflicts more than 95% of the patients [14], which is, however, not much reflected in animal AD models research.